Literature DB >> 23296100

Manganese-induced oxidative DNA damage in neuronal SH-SY5Y cells: attenuation of thymine base lesions by glutathione and N-acetylcysteine.

Adrienne P Stephenson1, Jeffrey A Schneider, Bryant C Nelson, Donald H Atha, Ashok Jain, Karam F A Soliman, Michael Aschner, Elizabeth Mazzio, R Renee Reams.   

Abstract

Manganese (Mn) is an essential trace element required for normal function and development. However, exposure to this metal at elevated levels may cause manganism, a progressive neurodegenerative disorder with neurological symptoms similar to idiopathic Parkinson's disease (IPD). Elevated body burdens of Mn from exposure to parental nutrition, vapors in mines and smelters and welding fumes have been associated with neurological health concerns. The underlying mechanism of Mn neurotoxicity remains unclear. Accordingly, the present study was designed to investigate the toxic effects of Mn(2+) in human neuroblastoma SH-SY5Y cells. Mn(2+) caused a concentration dependent decrease in SH-SY5Y cellular viability compared to controls. The LD50 value was 12.98 μM Mn(2+) (p<0.001 for control vs. 24h Mn treatment). Both TUNEL and annexin V/propidium iodide (PI) apoptosis assays confirmed the induction of apoptosis in the cells following exposure to Mn(2+) (2 μM, 62 μM or 125 μM). In addition, Mn(2+) induced both the formation and accumulation of DNA single strand breaks (via alkaline comet assay analysis) and oxidatively modified thymine bases (via gas chromatography/mass spectrometry analysis). Pre-incubation of the cells with characteristic antioxidants, either 1mM N-acetylcysteine (NAC) or 1mM glutathione (GSH) reduced the level of DNA strand breaks and the formation of thymine base lesions, suggesting protection against oxidative cellular damage. Our findings indicate that (1) exposure of SH-SY5Y cells to Mn promotes both the formation and accumulation of oxidative DNA damage, (2) SH-SY5Y cells with accumulated DNA damage are more likely to die via an apoptotic pathway and (3) the accumulated levels of DNA damage can be abrogated by the addition of exogenous chemical antioxidants. This is the first known report of Mn(2+)-induction and antioxidant protection of thymine lesions in this SH-SY5Y cell line and contributes new information to the potential use of antioxidants as a therapeutic strategy for protection against Mn(2+)-induced oxidative DNA damage.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23296100      PMCID: PMC3617125          DOI: 10.1016/j.toxlet.2012.12.024

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  44 in total

Review 1.  Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels.

Authors:  M Aschner
Journal:  Neurotoxicology       Date:  2000-12       Impact factor: 4.294

2.  Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.

Authors:  Rosemarie M Bowler; Harry A Roels; Sanae Nakagawa; Marija Drezgic; Emily Diamond; Robert Park; William Koller; Russell P Bowler; Donna Mergler; Maryse Bouchard; Donald Smith; Roberto Gwiazda; Richard L Doty
Journal:  Occup Environ Med       Date:  2006-10-03       Impact factor: 4.402

Review 3.  Occupational metal exposures and the risk of Parkinson's disease.

Authors:  J M Gorell; B A Rybicki; C Cole Johnson; E L Peterson
Journal:  Neuroepidemiology       Date:  1999       Impact factor: 3.282

4.  Oxidative stress involves in astrocytic alterations induced by manganese.

Authors:  Chun-Jung Chen; Su-Lan Liao
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

5.  Welding-related parkinsonism: clinical features, treatment, and pathophysiology.

Authors:  B A Racette; L McGee-Minnich; S M Moerlein; J W Mink; T O Videen; J S Perlmutter
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

6.  Effects of manganese on oxidative stress in CATH.a cells.

Authors:  Cynthia G Worley; David Bombick; Jeffrey W Allen; R Lee Suber; Michael Aschner
Journal:  Neurotoxicology       Date:  2002-07       Impact factor: 4.294

7.  The role of dopamine in manganese-induced oxidative injury in rat pheochromocytoma cells.

Authors:  K Seth; A K Agrawal; I Date; P K Seth
Journal:  Hum Exp Toxicol       Date:  2002-03       Impact factor: 2.903

8.  Manganese + 2 exhibits dynamic binding to multiple ligands in human plasma.

Authors:  J W Critchfield; C L Keen
Journal:  Metabolism       Date:  1992-10       Impact factor: 8.694

9.  Staurosporine induces a neuronal phenotype in SH-SY5Y human neuroblastoma cells that resembles that induced by the phorbol ester 12-O-tetradecanoyl phorbol-13 acetate (TPA).

Authors:  A Jalava; J Heikkilä; M Lintunen; K Akerman; S Påhlman
Journal:  FEBS Lett       Date:  1992-03-30       Impact factor: 4.124

10.  Role of dopamine in manganese neurotoxicity.

Authors:  M Parenti; L Rusconi; V Cappabianca; E A Parati; A Groppetti
Journal:  Brain Res       Date:  1988-11-15       Impact factor: 3.252

View more
  26 in total

1.  Minocycline increases the activity of superoxide dismutase and reduces the concentration of nitric oxide, hydrogen peroxide and mitochondrial malondialdehyde in manganese treated Drosophila melanogaster.

Authors:  Marylú Mora; Ernesto Bonilla; Shirley Medina-Leendertz; Yanauri Bravo; José Luis Arcaya
Journal:  Neurochem Res       Date:  2014-04-23       Impact factor: 3.996

2.  Toxicity assessment of the water used for human consumption from the Cameron/Tuba City abandoned uranium mining area prior/after the combined electrochemical treatment/advanced oxidation.

Authors:  Goran Gajski; Višnja Oreščanin; Marko Gerić; Robert Kollar; Ivanka Lovrenčić Mikelić; Vera Garaj-Vrhovac
Journal:  Environ Sci Pollut Res Int       Date:  2014-08-05       Impact factor: 4.223

3.  p73 gene in dopaminergic neurons is highly susceptible to manganese neurotoxicity.

Authors:  Dong-Suk Kim; Huajun Jin; Vellareddy Anantharam; Richard Gordon; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2016-04-20       Impact factor: 4.294

Review 4.  Redox dynamics of manganese as a mitochondrial life-death switch.

Authors:  Matthew Ryan Smith; Jolyn Fernandes; Young-Mi Go; Dean P Jones
Journal:  Biochem Biophys Res Commun       Date:  2017-02-03       Impact factor: 3.575

5.  Manganese-induced Neurotoxicity: From C. elegans to Humans.

Authors:  Pan Chen; Sudipta Chakraborty; Tanara V Peres; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Res (Camb)       Date:  2015-03-01       Impact factor: 3.524

6.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

7.  Attenuation of ecstasy-induced neurotoxicity by N-acetylcysteine.

Authors:  Sara Soleimani Asl; Bita Saifi; Abolhasan Sakhaie; Somayeh Zargooshnia; Mehdi Mehdizadeh
Journal:  Metab Brain Dis       Date:  2014-08-06       Impact factor: 3.584

8.  Iron depletion increases manganese uptake and potentiates apoptosis through ER stress.

Authors:  Young Ah Seo; Yuan Li; Marianne Wessling-Resnick
Journal:  Neurotoxicology       Date:  2013-06-10       Impact factor: 4.294

9.  The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development.

Authors:  Xinglu Huang; Fan Zhang; Xiaolian Sun; Ki-Young Choi; Gang Niu; Guofeng Zhang; Jinxia Guo; Seulki Lee; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2014-01       Impact factor: 12.479

10.  Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models.

Authors:  Bin Wu; Haiqing Cai; Shen Tang; Yilu Xu; Qianqian Shi; Lancheng Wei; Ling Meng; Ning Zhang; Xinhang Wang; Deqiang Xiao; Yunfeng Zou; Xiaobo Yang; Xiyi Li; Cailing Lu
Journal:  Neurotherapeutics       Date:  2020-09-21       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.